flesinoxan

Known as: p-fluoro-N-(2-(4-(2-(hydroxymethyl)-1,4-benzodioxan-5-yl)-1-piperazinyl)ethyl)benzamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2002
2002
Rationale: Recently, a new putative animal model of anxiety, "light-enhanced startle" was introduced. By placing a rat in a… (More)
  • figure 1
Is this relevant?
1999
1999
A short-term treatment with flesinoxan (2.5 and 5 mg/kg/day x 2 days, s.c., delivered using osmotic minipumps) decreased… (More)
Is this relevant?
1998
1998
This study examined the influence of the highly selective 5-HT1A receptor ligands, flesinoxan, S 15535, and WAY 100,635, upon the… (More)
Is this relevant?
1997
1997
Two tests were carried out to compare the stimulatory (i.e., prosexual) effects of the 5-HT1A receptor agonists flesinoxan and 8… (More)
Is this relevant?
1995
1995
The effects of the selective 5-HT1A receptor agonist flesinoxan on neuroendocrine function, temperature, and behavior were… (More)
Is this relevant?
1995
1995
The effects of the selective 5-HT1A receptor agonist flesinoxan on neuroendocrine function, temperature, and behavior were… (More)
Is this relevant?
1995
1995
Flesinoxan is a high affinity and selective 5-hydroxytryptamine1A (5-HT1A) ligand which, unlike the 5-HT1A agonists of the… (More)
Is this relevant?
1990
1990
Different groups of rats were trained to discriminate either 0.3 mg/kg of flesinoxan (N = 13) or 0.1 mg/kg of 8-OH-DPAT (N = 7… (More)
Is this relevant?
1988
1988
Flesinoxan, a new phenylpiperazine derivative has been shown to lower blood pressure in different species after both oral and i.v… (More)
Is this relevant?